Clinical Trial Update: Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating patient-reported outcomes for teriflunomide treatment in relapsing multiple sclerosis, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2016-12-06